Saccharomyces cerevisiae has two homologous hexokinases, I and II; they are 78% identical at the amino acid level. Either enzyme allows yeast cells to ferment fructose. Mutant strains without any hexokinase can still grow on glucose by using a third enzyme, glucokinase. Hexokinase II has been implicated in the control of catabolite repression in yeasts. We constructed null mutations in both hexokinase genes, HXK1 and HXK2, and studied their effect on the fermentation of fructose and on catabolite repression of three different genes in yeasts: SUC2, CYCI, and GALIO. The results indicate that hxkl or hxk2 single null mutants can ferment fructose but that hxkl hxk2 double mutants cannot. The hxk2 single mutant, as well as the double mutant, failed to show catabolite repression in all three systems, while the hxkl null mutation had little or no effect on catabolite repression.
In the budding yeast Saccharomyces cerevisiae, there are two homologous but nonidentical isoenzymes of the glycolytic enzyme hexokinase: hexokinase I and II, encoded respectively by the genes HXKJ and HXK2. These are the only enzymes that phosphorylate fructose in S. cerevisiae. Maitra and colleagues (31) found that strains with point mutations in both the HXKI and HXK2 genes failed to use fructose as a carbon source. These mutants can still grow on glucose presumably by using the glucose-specific enzyme glucokinase, specified by the GLKI gene (35) .
Catabolite repression, or glucose repression, is a global regulation of the genes controlling the metabolism of many carbon sources. Cells grown on glucose generally express lower levels of the enzymes for metabolizing other carbon sources than when they are grown on poorer, "nonrepressing" carbon sources such as glycerol or lactate. This phenomenon has been observed in many microorganisms, including Escherichia coli (See reviews in references 15, 33, and 34) and S. cerevisiae (e.g., see references 8, 9, 13, 14, 18, 25, 38, 39 , and references therein). Hexokinase II, in addition to its glycolytic activity, has been implicated in the control of catabolite repression in S. cerevisiae. Work in other laboratories has found that point mutations in the HXK2 gene are able to relieve catabolite repression (17) (18) (19) 21) .
Both of the HXKI and HXK2 genes have been cloned independently by other groups (20, 22, 60) and in this laboratory (55) , and the sequences of the two genes are now available (23, 29, 55) . The availability of the cloned genes allows the use of powerful molecular and genetic manipulations (4) including in vitro mutagenesis (6, 52, 53) , which we have used to generate a large number of mutants. Here we report the phenotypic characterizations of the in vitrogenerated null mutations of the HXKI and HXK2 genes, after they are introduced back into the yeast genome. We found that the hxkl hxk2 double null strain, as expected, failed to ferment fructose. Our results also indicate that the null phenotype of the HXKI gene is not much different from that of wild type but that the null mutants of the HXK2 gene fail to show catabolite repression in all three systems that were examined: the SUC2 gene (7, 8, 10) encoding invertase, MATERIALS AND METHODS Strains and plasmids. The yeast strains used in this study, their genotypes, and their sources are listed in Table 1 . Subclones of the HXKI and HXK2 loci were made for various purposes by standard procedures (36) . A 6.2-kilobase (kb) ClaI-BamHI fragment of the HXKI locus was inserted into the ClaI-BamHI sites of pBR322 (3) to give pJJ101 (Fig. 1A) . A 3.7-kb EcoRI fragment of the HXK2 locus (23, 55) was subcloned into the EcoRI site of pRB290 (YIp5 [5] without its Hindlll site [50] ) to give pRB309 (Fig.  1B) . The same EcoRI fragment was also inserted into the EcoRI site of YCp50 (C. Mann, personal communication; see reference 30 for map) to give a yeast centromere plasmid carrying the HXK2 gene (pRB313).
Construction of null mutations. The in vitro manipulations were done by standard procedures as described by Maniatis et al. (36) . A 2.3-kb SalI-XhoI LEU2 fragment (1) was inserted into a Sall site in the coding region of the HXKJ gene (29, 55) . The transplacement to introduce the hxkl::LEU2+ allele onto the chromosome was performed essentially as previously described (49) by selecting for leucine prototrophy in a leu2-3,2-112 background (DBY1315). Three null mutations of the HXK2 gene were constructed in pRB309, a derivative of the integrating vector YIp5 (5) with the URA3 gene (47, 48) , by deleting various extents of the HXK2 gene (Fig. 1B) . Plasmids carrying these null mutations of the HXK2 gene were then integrated at the HXK2 locus as previously described (44) selecting for uracil prototrophy in a ura3-52 and hxkl ::LEU2+ background. Subsequently, the Ura-segregants were selected on medium containing 5-fluoroorotic acid, and the hxkl hxk2 double mutants were screened for the inability to ferment fructose. The single mutants with different hxk2 alleles were then obtained by transformation with a wild-type HXKI fragment under selection for fructose fermentation.
The gal8O: :HIS3+ disruption was constructed by replacing a 0.56-kb internal BglII fragment of the GAL80 gene in clone pRY176 (62) with the 1.8-kb BamHI fragment containing the HIS3 gene (58) . The transplacement (49) of gal8O::HIS3+ (9) . The sources of the other alleles are: leu2-3,2-112 from G. Fink; his3-200, a deletion made by M. Fasullo and P. Hieter (56; see map in reference 57); and gallO-120 (28) and tyri-501 from M. Johnston. The gal8O::HIS3' disruption was constructed for this study (see text for details) with a GAL8O DNA clone (43, 62) generously provided by R. Yocum. b These have the plasmid pJP100 (45) carrying a CYCI-lacZ+ fusion (from J. Pinkham and L. Guarente) integrated at the LEU2 locus. The order of the two alleles of the LEU2 gene is not known.
c These have the plasmid pRY183 (61) was done by selecting for histidine prototrophy in a his3-200 background.
DNA transformations of yeast cells were performed by the lithium acetate method described by Ito et al. (27) , with the modifications of Kuo and Campbell (30) .
Enzyme assays. For various enzyme assays, cells were harvested in the mid-exponential phase (Klett 50 to 70). Hexokinase assays were performed as previously described (2) with crude extract from cells grown in YEP-5% glucose medium (51) , and the protein content was determined by the Lowry method (32). Invertase assays were carried out as before (24) on cells grown on either repressing media containing 5% glucose or derepressing media containing 2% lactate, as were P-galactosidase assays (40) for strains with the CYCI-lacZ+ fusion. For ,-galactosidase assays of strains with the GAL10-lacZ+ fusion, cells were grown in repressing media containing 5% glucose or 5% glucose plus 2% galactose or in derepressing medium containing 2% galactose.
Genetic methods. Standard genetic procedures of crossing, sporulation, and tetrad analysis were followed (41, 51 (23, 55) . The HXK2-bearing plasmid pRB309, the deletions hxk2-202 and hxk2-212, and the frameshift mutation hxk2-208 are shown in Fig. 1B . These null mutations were introduced back into the yeast genome by integration directed at the HXK2 locus followed by excision of the plasmid and loss of the wild-type allele. DNA gel transfer and hybridization experiments were performed, and the results showed the expected hybridization patterns for the null mutations (Fig. 1C and D) .
Growth on fructose and hexokinase activities. In yeasts, the hexokinases are the only two enzymes that phosphorylate fructose, thus allowing fructose to enter glycolysis and to be used as a carbon and -energy source. The null mutants showed the expected phenotypes for growth on media containing fructose as the carbon and energy source: the (Table 2) .
Effect of HXK null mutations on catabolite repression of SUC2. To examine the possible effects of the various null mutations of the HXKJ and HXK2 genes on the expression of SUC2, a catabolite repression-sensitive gene (7-9), we assayed the specific activity of invertase, the product of the SUC2 gene, in the wild type and the various hxk mutant strains under repressing and derepressing conditions. We found that under the repressing condition of high glucose the hxk2 single mutant (strain DBY2226) and the hxkl hxk2 double mutant (DBY2219) had high levels of invertase activity, while the hxkl single mutant and the wild type had very low levels of invertase activity (Table 2) . Thus, the hxk2 null phenotype is apparently complete loss of catabolite repression.
The small variations in the constitutive invertase level of strains DBY2226 and DBY2219 are not related to catabolite repression but instead are the consequence of high osmolarity of the 5% glucose medium. In control experiments (data not shown), addition of sorbitol to 5% eliminated these differences.
The strains DBY2226 and DBY2219 carry a large deletion of the HXK2 gene that extends well beyond the ends of the coding sequence. This raised the possibility that neighboring gene(s) might be affected. To test whether the failure to repress invertase expression in high-glucose medium is due solely to the absence of the HXK2 function, we tested the invertase activity of hxk2 mutants carrying internal null alleles hxk2-208 and hxk2-212 (Fig. 1B) (Table 3) , even though the specific activity of hexokinase I in the cells on glucose now is comparable to that of single-copy hexokinase II.
Effect of HXK null mutations on catabolite repression of CYCI. We examined the effects of the null mutations on the expression of another catabolite repression-sensitive gene, CYCI (25) . A CYCI-lacZ+ fusion (containing UAS2 only [45] ) was integrated at the LEU2 locus and subsequently put into different HXKI and HXK2 backgrounds by crosses. The UAS2 in this fusion contains a mutation (UP1 [25] ) which increases both the repressed and derepressed expression by 5-to 10-fold but does not affect catabolite repression or other aspects of the regulation of the CYCI gene expression (25) . The expression of the CYCI gene was monitored by assaying for ,-galactosidase activity in different strains. The results were similar to those for the SUC2 gene ( Table 2) .
Expression of GALIO in different HXK backgrounds. The SUC2 and CYCJ genes are similar in that they do not require the function of an external inducer for expression. To test whether hexokinase II is involved in the catabolite repression of a gene requiring an external inducer for expression, we examined the expression of the GALIO gene (16) using a GAL1O-lacZ+ fusion (61) . If the cells were gal80, the pattern of the GAL1O-lacZ+ fusion expression paralleled those of the SUC2 and CYCI genes ( Table 4 ). The elimination of the HXK2 function alone resulted in enzyme levels being con- stitutively high, comparable to the wild-type fully derepressed level (on galactose). This is true whether the cells were induced on galactose first or not. Furthermore, the presence of galactose in the repressing medium makes no difference. However, if the cells were GAL80+, the levels of expression were below detection in the absence of the inducer galactose. Even in the presence of galactose, cells had much lower levels in high glucose than the corresponding gal80 strains of the HXK genotype; even the hxkl hxk2 double mutant had a level much lower than the wild-type derepressed level (Table 4) , in contrast to the SUC2 and CYCI genes ( Table 2 ). These observations are consistent with an effect of glucose on galactose uptake, as described below.
DISCUSSION
Previous results on the function of the hexokinases in catabolite repression have come from studies with point mutations (17) (18) (19) 21 ). Entian and colleagues (17) have isolated mutations in the HXK2 gene causing low hexokinase activity and found them to lead to failure of catabolite repression. They have also isolated mutations both in the HXK2 gene and in a second gene HEX2 which lead to high hexokinase activity and!lack of catabolite repression (18, 19) . Mutations of the first kind could be loss of function mutations but need not be so; those of the second kind do not lead to loss of the hexokinase activity. It is therefore not clear whether the lack of catabolite repression is due to loss of function or altered function. This makes the interpretation of the results difficult, especially in terms of determining whether hexokinase II acts as a regulator in a positive or negative fashion. Here, we found that one of the null phenotypes of the HXK2 gene is the failure of catabolite repression; loss of hexokinase II alone caused a 100-fold increase of the expression of both the SUC2 and CYCI genes under repressing condition. That the null phenotype of the HXK2 gene is constitutive expression of the SUC2 and CYCJ gene argues that hexokinase II acts in a negative fashion in catabolite repression. In contrast, the effect of loss of the HXKI function on catabolite repression was insignificant.
Nevertheless, the results with the HXKI gene on multicopy plasmids indicate that hexokinase I has the potential of conferring partial catabolite repression. The observation that the restorative effect of the multicopy HXKI gene is smaller than that of the single-copy HXK2 gene suggests that there is some qualitative difference between the two hexokinases. Models have been proposed (19) hypothesizing that hexokinase I and II are sufficiently different from each other so that hexokinase II is the only one of the two that is involved in catabolite repression. Our results are consistent with those models because the normal single copy of the HXKI gene has little or nq effect on catabolite repression.
On the basis of the presence of mutations in the HXK2 gene that cause a defect in catabolite repression but retain high hexokinase activity, Entian and Frohlich (19) proposed that hexokinase II is a bifunctional protein with separate domains for catalytic and regulatory activities. Our results here that null mutations in the HXK2 gene cause loss of both catabolite repression and hexokinase activity of hexokinase II do not contradict such a model; however, they do not rule out other explanations either. Our preliminary results with point mutations of the HXK2 gene show that catabolite repression-defective mutations with high hexokinase activity do not cluster to one part of the gene (data not shown). These results do not support the two-domain model.
The effect of the hexokinases on the expression of the GALJO gene seems to be somewhat more complicated at first glance. The results for the GAL10-IacZ+ fusion in the absence of the GAL80 function are very similar to those found with the SUC2 and CYCI genes. However, when the GAL80 function was present, the results were quite different. The GAL80 gene product acts as an inhibitor of the GAL4 protein in the absence of the inducer galactose (16). Matern and Holzer (37) found that glucose has a strong inhibitory effect on the function of the galactose permease encoded by the GAL2 gene. This could explain why the hxkl hxk2 GAL80+ strain has activity in medium containing glucose and galactose that is 20-fold lower than the fully derepressed level. The high glucose inhibits the permease, preventing enough galactose from entering the cells to counter the inhibitory effect of the functional GAL80 protein that is present. Matsumuto et al. (38, 39) have identified three genes that affect the catabolite repression of the galactose genes, GAL82, GAL83, and REG]. They found the GAL82 and GAL83 functions to be in the same pathway and the REG] function to be in a separate pathway also affecting the SUC2 gene. In the absence of the GAL80 function, a The results for the GALI gene are calculated from the data in Table 3 of Matsumoto et al. (39) by normalizing to the wild-type derepressed level; the results for the GALIO gene are calculated from data in Table 4 of this study in the same way. Glu, Glucose; gal, galactose.
MOL. CELL. BIOL. recessive mutations in either of the two pathways resulted in partial derepression (Table 5) , and combination of mutations in both pathways gave full derepression. In the presence of the GAL80 function, however, mutations in either or both of the pathways had much smaller effects (Table 5 ). The combination of mutations in both the GAL82, GAL83 pathway and the REG] pathway showed results remarkably similar to those of the hxk2 mutant (Table 5) .
In this study, we examined the effects of null mutations of the HXKI and HXK2 genes on three different genes: SUC2, CYCI, and GALIO. Invertase is the enzyme that hydrolyzes sucrose, while cytochrome c, the product of the CYCI gene, is involved in the electron transport chain of respiration. The GAL1O gene product is the third enzyme of galactose metabolism, epimerase. Furthermore, the expression of the SUC2 and CYC1 genes does not require an external inducer, but the expression of the third gene, GALJO, does need the function of the inducer galactose. Our results indicate that hexokinase II is required for the catabolite repression of all three genes. Moreover, mutation in SNFJ (11, 12) , a gene affecting the catabolite repression of several systems including the SUC2 gene, the galactose genes, and the maltose genes (8) , was found to be epistatic to a recessive hxk2 mutation (42) . This argues that hexokinase II functions earlier than the SNFJ gene product in the regulatory pathway(s) of catabolite repression. The striking similarity of the effects on the galactose genes between our hxk2 null mutation and the combination of ga182 (gal83) and regi mutations again supports the notion that hexokinase II is common to all these pathways and that it functions at a stage before pathways branch for different systems. Because hexokinase is intimately involved in the early metabolism of glucose, it is most plausible that hexokinase II is involved in the earliest steps of catabolite repression, the assessment of available metabolizable carbon source.
